Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Tyagi

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 6, 2005
Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosisIan M Rosenthal, Kathy Williams, Sandeep Tyagi, et al.
American Journal of Respiratory and Critical Care Medicine|October 28, 2003
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosisEric L Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2006
Potent twice-weekly rifapentine-containing regimens in murine tuberculosisIan M Rosenthal, Kathy Williams, Sandeep Tyagi, et al.
Mycobacterial Diseases : Tuberculosis & Leprosy|December 20, 2014
Revisiting Anti-tuberculosis Activity of Pyrazinamide in MiceDeepak V Almeida, Sandeep Tyagi, Si-Yang Li, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2025
The KasA inhibitor JSF-3285 improves the sterilizing activity of bedaquiline-pretomanid-containing regimens in a mouse model of tuberculosisHeena Soni, Sandeep Tyagi, Kishor Mane, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2009
Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosisKathy N Williams, Steven J Brickner, Charles K Stover, et al.
American Journal of Respiratory and Critical Care Medicine|July 5, 2013
Assessment of clofazimine activity in a second-line regimen for tuberculosis in miceJacques H Grosset, Sandeep Tyagi, Deepak V Almeida, et al.
Plos Neglected Tropical Diseases|January 7, 2014
Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans diseasePaul J Converse, Yalan Xing, Ki Hyun Kim, et al.
The Journal of Infectious Diseases|January 30, 2020
Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of TuberculosisKristina M Bigelow, Amelia N Deitchman, Si-Yang Li, et al.
American Journal of Respiratory and Critical Care Medicine|August 13, 2004
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosisEric L Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
American Journal of Respiratory and Critical Care Medicine|September 6, 2005
Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosisIan M Rosenthal, Kathy Williams, Sandeep Tyagi, et al.
American Journal of Respiratory and Critical Care Medicine|October 28, 2003
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosisEric L Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2006
Potent twice-weekly rifapentine-containing regimens in murine tuberculosisIan M Rosenthal, Kathy Williams, Sandeep Tyagi, et al.
Mycobacterial Diseases : Tuberculosis & Leprosy|December 20, 2014
Revisiting Anti-tuberculosis Activity of Pyrazinamide in MiceDeepak V Almeida, Sandeep Tyagi, Si-Yang Li, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2025
The KasA inhibitor JSF-3285 improves the sterilizing activity of bedaquiline-pretomanid-containing regimens in a mouse model of tuberculosisHeena Soni, Sandeep Tyagi, Kishor Mane, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2009
Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosisKathy N Williams, Steven J Brickner, Charles K Stover, et al.
American Journal of Respiratory and Critical Care Medicine|July 5, 2013
Assessment of clofazimine activity in a second-line regimen for tuberculosis in miceJacques H Grosset, Sandeep Tyagi, Deepak V Almeida, et al.
Plos Neglected Tropical Diseases|January 7, 2014
Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans diseasePaul J Converse, Yalan Xing, Ki Hyun Kim, et al.
The Journal of Infectious Diseases|January 30, 2020
Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of TuberculosisKristina M Bigelow, Amelia N Deitchman, Si-Yang Li, et al.
American Journal of Respiratory and Critical Care Medicine|August 13, 2004
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosisEric L Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.
Pageof 8